Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Study on Edoxaban Treatment in Routine Clinical Practice for Patients With Non-valvular Atrial Fibrillation in China

NCT04747496 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT04747496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04747496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Study on Edoxaban Treatment in Routine Clinical Practice for Patients With Non-valvular Atrial Fibrillation in China
Lead sponsor
Daiichi Sankyo
Phase
Observational
Overall status
Completed
Start date
February 26, 2021
Completion date
November 27, 2024
Enrollment
5,000 (actual)
Sites
97

Conditions

As the registry lists them; a condition with its own page is linked.

non-valvular atrial fibrillation